Sign Out
Click on icon to see table/diagram/imageRespiratory, thoracic and mediastinal disorders: Incidence unknown: Epistaxis.
Gastrointestinal disorders: Incidence unknown: Dry mouth.
Skin and subcutaneous tissue disorder: Incidence unknown: Erythema multiforme, Dermatitis exfoliative.
Eye disorder: Incidence unknown: Vision blurred, Visual impairment.
During cataract and glaucoma surgery a small pupil situation, known as Intraoperative Floppy Iris Syndrome (IFIS), has been reported during post-marketing surveillance. As with other alpha-blockers drowsiness can occur.
Post-marketing experience: In addition to the adverse events listed previously, atrial fibrillation, arrhythmia, tachycardia and dyspnoea have been reported in association with tamsulosin use. Because these spontaneously reported events are from the worldwide post-marketing experience, the frequency of events and the role of tamsulosin in their causation cannot be reliably determined.
View ADR Reporting Link
Lanjutkan dengan Google